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Early ischemic changes 
A B S T R A C T   
Introduction: Patients with small core infarction and salvageable penumbra are likely to benefit from endovas-
cular treatment (EVT). As computed tomography perfusion imaging (CTP) is not always available 24/7 for pa-
tient selection, many patients are transferred to stroke centers for CTP. We compared automatically measured 
infarct core volume (NCCTcore) from the non-contrast computed tomography (NCCT) with ischemic core volume 
(CTPcore) from CTP and the outcome of EVT to clarify if NCCTcore measurement alone is sufficient to identify 
patients that benefit from transfer to stroke centers for EVT. 
Patients and methods: We included all consecutive stroke-code patients imaged with both NCCT and CTP at 
Helsinki University Hospital during 9/2016–01/2018. NCCTcore and CTPcore volumes were automatically 
calculated from the acute NCCT images. Follow-up infarct volume (FIV) was measured from 24 h follow-up NCCT 
to evaluate efficacy of EVT. To study whether NCCTcore could be used to identify patients eligible to EVT, we sub- 
grouped patients based on NCCTcore volumes (>50 mL and ≥ 70 mL). 
Results: Out of 1743 patients, baseline NCCTcore, CTPcore and follow-up NCCT was available for 288 patients. 
Median time from symptom onset to baseline imaging was 74 min (IQR 52–118), and time to follow-up imaging 
24.15 h (22.25–26.33). Baseline NCCTcore was 20 mL (10–42), CTPcore 4 mL (0–16), and FIV 5 mL (1–49). Out of 
288 patients, 23 had NCCTcore ≥ 70 mL and 26 had CTPcore ≥ 70 mL. NCCTcore and CTPcore performed similarly 
well in predicting large FIV (≥70 ml). 
Conclusion: NCCTcore is a promising tool to identify patients that are not eligible to EVT due to large ischemic 
cores at baseline imaging.   
1. Introduction 
Acute ischemic stroke is usually caused by an embolic or thrombo-
embolic occlusion of a cerebral artery, which results in reduced cerebral 
blood flow (CBF) in the brain. This leads to brain ischemia, which can be 
divided into two distinct components, 1. the irreversibly damaged 
“core” infarction and 2. the ischemic, but viable surrounding tissue 
called penumbra [1–3]. Mechanical endovascular treatment (EVT) of 
large vessel occlusion (LVO) has been proven effective treatment in 
acute stroke care and the time-window for EVT has increased up to 24 h 
[4–11]. Recent large clinical trials have used perfusion imaging as se-
lection tool for EVT inclusion and patients most likely to benefit from 
EVT are those with a relatively small volume of ischemic core (infarct 
core), LVO and salvageable brain tissue (volume of perfusion lesion, 
mismatch volume) measured by Tmax threshold of 6 s (>15 ml (mL) [12]. 
Based on previous studies, Tmax > 6 s is considered a reasonable estimate 
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of tissue at risk of infarction in the absence of reperfusion and the size of 
penumbra is considered as one of the prognostic biomarkers 
[4–7,11,12]. 
RAPID automated imaging analysis has been proven effective con-
cerning computed tomography perfusion imaging (CTP) in predicting 
the final infarct volume as well as tissue at risk in large clinical trials 
although other commercial CTP software are also on market [4,11,12]. 
As infarct core growth is individual, CTP is often useful in the eval-
uation of most acute stroke code patients screened for potential EVT. 
The American Heart Association guidelines (AHA) recommend to follow 
the study inclusion and exclusion criteria of the recent EVT trials when 
considering EVT in patients in the 6 to 24 h time window [4,11]. This 
makes proper identification of suitable patients impossible in hospitals 
without availability of CTP or comprehensive magnetic resonance im-
aging leading to many futile secondary transports to comprehensive 
stroke centers or withholding potentially beneficial treatments of pa-
tients, depending on the local policies. An experimental feature of the 
machine learning based e-ASPECTS software (Brainomix Ltd.) can pro-
vide a volumetric measure of early ischemic changes (EIC) detected on 
non-contrast computed tomography (NCCT) images (NCCTcore). 
NCCTcore might be useful in patient selection if ischemic core mea-
surement by CTP (CTPcore) is not available. 
Aims and hypothesis. 
The aim of the study is to retrospectively compare NCCTcore and 
CTPcore in selection of acute recanalization treatment patients (EVT) 
among stroke code patients to clarify whether NCCTcore measurement 
alone is sufficient to identify patients with large infarct core (>50 mL 
and ≥ 70 mL) and thus do not benefit from recanalization treatment 
attempts. 
2. Methods 
We performed a single-center, retrospective analysis of imaging 
findings of all consecutive acute stroke patients (Stroke Code) at Hel-
sinki University Hospital (HUS) based on the Helsinki stroke quality 
registry (HSQR). Ethical approval was not sought for the present study 
and informed consent was waived due to the retrospective nature of the 
study. This study was completed in accordance with the Helsinki 
Declaration as revised in 2013. NCCT is the first-line imaging modality 
for stroke code patients in our hospital. All patients evaluated for po-
tential intravenous thrombolysis (IVT) or EVT for acute ischemic stroke 
were considered as stroke code patients and treatment decisions were 
made based on clinical symptoms and imaging findings at HUS. Multi-
modal imaging, usually CTP (RAPID® software, iSchemaView Inc., 
Golden Park, CA, USA) and computed tomography angiography (CTA) 
were done according to the decision of the treating neurologist based 
our local guideline which are in line with the current AHA guidelines 
[4,11]. No visualization of penumbra by CTP is required by Helsinki 
protocol in the 0-6 h time window for clinically obvious ischemic 
strokes. The NCCT is used to rule out contraindications (brain 
Fig. 1. Illustrates baseline non-contrast computed tomography (NCCT) (A), volumetric measure of early ischemic changes detected on NCCT in milliliters (mL) (B), 
estimated relative cerebral blood flow (CBF) below 30% of normal brain (LEFT) and tissue at risk of infarction in the absence of reperfusion (Tmax > 6 s, RIGHT) in 
baseline computed tomography perfusion imaging in mL (C) and follow-up infarction volume in 24 h follow-up NCCT image (D) in a 64-year-old patient with 
ischemia in MCA (middle cerebral artery) territory. 
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hemorrhagia and extensive vascular degeneration) and CTA is taken 
after initiation of thrombolysis to evaluate whether EVT is indicated. 
A follow-up NCCT imaging of the brain at 24 h (±6 h) was performed 
for all patients who underwent IVT or EVT. Clinical parameters (sex, 
age, glucose, INR, blood pressure), National Institute of Health Stroke 
Scale (NIHSS) score at baseline and 24 h and modified Rankin scale 
(mRS) at 3 months were registered. Symptomatic intracerebral hemor-
rhage (sICH) was assessed according to European Co-operative Acute 
Stroke Study-II (ECASS 2) criteria [13]. Recanalization was defined with 
modified Treatment in Cerebral Infarction (mTICI)) scale as successful 
(score 2b or 3) or futile (score 0, 1, or 2a) by the performing interven-
tional radiologist [14]. Favorable outcome was defined as 0–2 on 
modified Rankin scale (mRS). 
2.1. Imaging protocol 
NCCT and CTP were performed on a Definition AS Siemens (Siemens, 
Erlangen, Germany) 128-section scanner with slice thickness of 1 mm. 
The following parameters were used for the CTP acquisition: slice 
thickness of 5 mm, collimator of 32 × 1.2 mm, 70kVp, and 135 mAs with 
total coverage of 100 mm. The plane of imaging was parallel to the floor 
of the anterior cranial fossa starting just above the orbits. Thirty cycles 
were obtained with a total scan time of 46 s. The CTP images were sent 
to RAPID® (iSchemaView Inc) in order to quantify ischemic core and 
volume of perfusion lesion. 
The CTPcore was defined as relative cerebral blood flow (CBF) below 
30% of normal brain [15]. Tmax threshold of 6 s was used as estimate of 
tissue at risk of infarction in the absence of reperfusion [12]. The volume 
of saved tissue was calculated as the difference of the volume with a Tmax 
exceeding 6 s and the follow-up infarct volume (FIV) (CTPTmax>6s-FIV). 
The volume of lost tissue was calculated as the difference of the FIV and 
the CTPcore (FIV- CTPcore). 
Alberta stroke program early CT score (ASPECTS) [16,17] score was 
automatically determined by using e-ASPECTS software [18,19]. e-AS-
PECTS volume feature (NCCTcore) was used to quantify ischemic core 
from the baseline NCCT in mL. 
Briefly, e-ASPECTS is based on a machine learning algorithm and 
was developed to detect signs of EIC on NCCT. In e-ASPECTS volume 
feature (NCCTcore, Brainomix Ltd.) patient-specific segmentation of the 
ASPECTS regions is computed, and the output score and result images 
are generated by classifying each region according to the evidence of 
ischemia contained within the probability map. NCCTcore is the volume 
of this probability map and comprise the sum of the voxels in which EIC 
have been identified which is converted in to a volumetric value in mL. 
Fig. 1 illustrates baseline NCCT, NCCTcore and CTPcore at baseline and 
FIV on follow-up NCCT in the same patient. 
The neuroradiologist (AA) was blinded to any other imaging 
including e-ASPECTS and RAPID software. He defined the territory and 
side of infarction and measured semi-automatically the FIV from the 
n=1743 (100%) 
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Fig. 2. Flowchart of the patients in the study. ICH; Intracerebral Hemorrhage, 
CTP; Computed Tomography Perfusion, EIC, Early Ischemic Changes, NCCT; 
Non-Contrast Computed Tomography. 
Table 1 
Cohort Characteristics of 288 acute stroke code patients imaged with non- 
contrast computed tomography (NCCT), computed tomography perfusion 
(CTP) and follow-up NCCT at 24 h  
Characteristics  Participants 
Age in years, mean (SD)  71 (±11) 
Male  162 (56) 
IVT/EVT/IVT + EVT  118 (41)/40 (14)/49 
(17) 
No recanalization treatment  81 (28) 
Wake-up stroke  66 (23) 
Time to imaging, min  74 (52–118) 
Time from baseline to follow-up imaging, h  24.15 (22.25–26.33) 
CTP < 6 h of symptom onset  198 (69) 
mRS for patients with recanalization 
treatment 
3–6 92 (44) 
Successful recanalization in EVT patients  63 (71) 




CTPcore > 50 mLb  36 (13) 
CTPcore > 70 mLb  26 (9) 
CTPcore volumeb in mL  4 (0–16) 
CTP Tmax > 6 s volumeb in mL  64 (5–14) 
Tmax > 6 s > 15 mLb  192 (67) 
Baseline NIHSS scorec  8 (4–15) 
Baseline ASPECTSc  10 (8–10) 
Baseline NCCTcorec in mL  20 (10–42) 
FIV, mL  5 (1–49) 
ACA or PCA ischemia only  33 (11) 
IVT;Intravenous Thrombolysis,EVT;Endovascular Treatment, mRS;modified 
Rankin Scale, Successful recanalization mTICI;modified Thrombolysis in Cere-
bral Infarction 2b or 3, sICH; Symptomatic Intracranial Hemorrhage, NIHSS;NIH 
Stroke Scale, ASPECTS;Alberta Stroke Program Early CT Score, FIV; Follow-up 
Infarct Volume, ACA;Anterior Cerebral Artery, PCA; Posterior Cerebral Artery. 
a According to the ECASS2 criteria. 
b CTP RAPID. 
c e-ASPECTS, e-ASPECTS volume feature. Data are n (%) or median (inter-
quartile range, IQR) unless otherwise stated. 
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follow-up NCCT by using the volume of interest (VOI) tool (syngo.via 
MM-Reading) and CT Neuro – workflow implemented in syngo.via 
(Siemens healthineers). Ischemic changes were identified visually and 
marked as region of interest (ROI). Those ROIs had mean Houndsfield 
units (HU) ranging from 25 to 31, while normal cerebral parenchyma 
was measured at mean > 42 HU. The “create VOI tool” was then applied 
to include all voxels situated within the before mentioned threshold at 
different slices of the same infarction. Edges were manually adjusted 
when necessary. 
2.2. Statistics 
Descriptive statistics were performed using SPSS, version 25.0 (IBM 
Corp., Armonk, NY, USA). Shapiro-Wilk test was used to assure 
normality on continuous variables. Categorical variables are presented 
as absolute values and percentages, continuous variables as mean ±
standard deviation (SD) if normally distributed or median (interquartile 
intervals, IQR) if not normally distributed. Medians between two groups 
(subgroups of successful recanalization, imaging>6 h of symptom onset, 
NCCTcore > 50 and ≥ 70 mLvolumes) versus all patients without signs of 
ACA or PCA ischemia only on follow-up imaging were analyzed using 
the Wilcoxon Signed Rank test or Mann–Whitney U test. Bland–Altman 
plots were used to illustrate the distribution of the difference in volu-
metric measurements (mL) between NCCTcore and CTPcore. The Bland- 
Altman plots enable visual assessment of the bias (mean difference in 
values obtained between the paired measurements), data scatter, and 
the relationship between magnitude of difference and size of measure-
ment. The horizontal lines above and below the bias line represent 95% 
limits of agreement and are defined with limits of agreement=bias ±
1.96 standard deviation. 
Receiver operating characteristics (ROC) curves were generated for 
both NCCTcore and CTPcore to analyze sensitivity and specificity of 
NCCTcore and CTPcore for dichotomized FIV >50 mL FIV ≥70 mL 
respectively. The standard error of ROC-curves were analyzed by the 
method of Hanley and McNeil. The statistical analysis plan specified a p 
value less than 0.05 as statistically significant. 
3. Results 
3.1. Patients 
We enrolled 1743 consecutive acute stroke code patients to the study 
(Fig. 2). Of those, 508 (29%) received IVT, EVT or both. 295 (17%) 
received IVT only, 97 (6%) received EVT only, and 116 (7%) both IVT 
and EVT. 1235 (71%) stroke code patients were not eligible for recan-
alization therapy (EVT or IVT) and 120 (7%) of all patients were diag-
nosed with ICH. 
660 out of the 1743 patients were imaged with CTP. Follow-up NCCT 
images were available for all patients that received IVT and/or EVT, and 
Fig. 3. Bland–Altman plot of the difference between NCCTcore and CTPcore 
volumes among (A) all 255 patients without anterior cerebral artery (ACA) or 
posterior cerebral artery (PCA) ischemia only on follow-up imaging, (B) pa-
tients with successful recanalization (modified Treatment in Cerebral Infarction 
2b or 3, n = 61) and (C) patients imaged >6 h of symptom onset (n = 79). 
Table 2 
Cohort Characteristics of 52 (NCCTcore > 50 mL) and 23 (NCCTcore ≥ 70 ml) 
acute stroke code patients imaged with non-contrast computed tomography 
(NCCT), computed tomography perfusion (CTP) and follow-up NCCT at 24 h.   
>50 mL 
N = 52 
≥70 mL 
N = 23 
IVT/EVT/IVT + EVT 26 (50)/16 (31)/ 11 
(21) 
9 (39) /7 (30)/4 
(17) 
No treatment 21 (40) 11 (47) 
Wake-up stroke 12 (23) 6 (26) 
Time to imaging, min 108 (61–185) 120 (54–206) 
Time from baseline to follow-up 
imaging, h 
24.58 (22.94–27.16) 25.25 (22.6.33) 
Imaging >6 h of symptom onset 20 (38) 11 (48) 
mRS 3–6 for patients with 
recanalization treatment 
6 (12) 2 (17) 
Successful recanalization in EVT 
patients 
8 (50) 3 (43) 
sICHa 0 (0) 0 (0) 
CTPcoreb, mL 45 (2–91) 92 (24–108) 
Tmax > 6 s > 15 mL 46 (86) 20 (87) 
NCCTcorec,mL 64 (56–83) 81 (76–132) 
FIV, mL 55 (15–208) 175 (60–255) 
MCA ischemia on follow-up imaging 52 (100) 23 (0) 
Volume of tissue saved in mL, mean 
(SD) 
33 (±96) -3 (±102) 
Volume of tissue lost in mL, mean (SD) 66 (±81) 96 (±91) 
ASPECTSc 6 (4–8) 5 (3–7) 
IVT;Intravenous Thrombolysis, EVT;Endovascular Treatment, mRS;modified 
Rankin Scale, TICI;Thrombolysis in Cerebral Infarction, sICH;Symptomatic 
Intracranial Hemorrhage, FIV; Follow-up Infarct Volume MCA;Middle Cerebral 
Artery, Volume of tissue saved (CTPTmax6s-lesion-FIV) and tissue lost (FIV- 
CTPcore). 
a According to the ECASS2 criteria. 
b CTP RAPID. 
c e-ASPECTS, e-ASPECTS volume feature. Data are n (%) or median (inter-
quartile range, IQR) unless otherwise stated. 
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in addition, for 80 patients that were imaged with CTP but who did not 
receive any recanalization therapy. Altogether CTP, NCCT images at 
baseline, and follow-up NCCT images were available for 297 patients. 9 
patients had to be excluded due to technical problems in RAPID output 
or NCCTcore image analysis. 
Final cohort of 288 patients consisted of 118 (41%) patients treated 
with IVT only, 40 (14%) with EVT only, 49 (17%) with both IVT and 
EVT and 81 (28%) patients with no acute recanalization treatment (IVT 
or EVT). Medians for time from symptom onset to baseline imaging and 
baseline to follow-up imaging were 74 min (IQR 52–118), and 24.15 h 
(IQR 22.25–26.33) respectively. 198 (69% patients) were imaged <6 h 
of symptom onset, for more clinical characteristics see Table 1. Median 
ASPECTS of the patients was 10 (IQR 8–10; supplementary appendix). 
As e-ASPECTS software detects signs of early ischemic damage in 
NCCT only in the middle cerebral artery (MCA) territory, we excluded 
the patients with ischemia only in the vascular territory of anterior or 
posterior cerebral artery (ACA, PCA) on follow-up imaging (n = 33, 
11%). 
CTPcore of the remaining 255 patients was smaller than the NCCTcore 
(3 mL; IQR 0–20 vs. 24 mL; IQR 10–44); the median FIV was 5 mL (IQR 
0–60). The median difference between NCCTcore and CTPcore was 12 mL 
(IQR 1–26, p < 0.001) and between NCCTcore and FIV 6 mL (IQR − 28- 
21, p > 0.05). 
We analyzed the difference between NCCTcore and CTPcore further to 
evaluate the effect of successful recanalization and the effect of imaging 
time on results. 61 out of 255 (24%) patients had successful recanali-
zation. In them, the median difference between NCCTcore and CTPcore 
was 9 mL (IQR-8-18), and between NCCTcore and FIV 6 mL (IQR − 32- 
25). The difference between NCCTcore and FIV was significantly smaller 
(p < 0.005) in patients with successful recanalization than in other 
patients. 
79 out 255 patients (31%) were imaged >6 h of symptom onset. The 
median difference between NCCTcore and CTPcore was 13 mL (IQR 
0.2–31) and between NCCTcore and FIV 0.4 mL (IQR –39-23). NCCTcore, 
did not significantly differ between the patients imaged >6 h of symp-
tom onset and other patients. 
Bland–Altman plots (Fig. 3) illustrate the difference between 
NCCTcore and CTPcore in (A) all 255 patients, (B) patients with successful 
recanalization and (C) patients imaged >6 h of symptom onset. 
3.2. NCCTcore and identification of EVT candidates 
To study whether NCCTcore values could be used in identification of 
EVT candidates without access to perfusion imaging, the patients were 
subgrouped based on NCCTcore volumes (Table 2) using the same cut-off 
volumes (>50 mL and ≥ 70 mL) that were used for exclusion in the 
recent large EVT trials [4,11]. Success of recanalization therapy was 
evaluated as volume of tissue saved in patients with acute recanalization 
treatment. 
NCCTcore volume was >50 mL in 52 (18%) and CTPcore > 50 mL in 36 
(13%) of the patients. NCCTcore volume was ≥70 mL in 23 (8%) and 
CTPcore ≥ 70 mL in 26 (9%) of the patients. All patients (100%) with 
both NCCTcore > 50 mL and NCCTcore volume was ≥70 mL had MCA 
ischemia on follow-up imaging. 20 (38%) patients with NCCTcore > 50 
mL and 11 (46%) with NCCTcore ≥ 70 mL were imaged >6 h of symptom 
onset. 
Fig. 4A illustrates baseline NCCTcore, and CTPcore volumes, FIV in 24 
h follow-up NCCT and volume of perfusion lesion (Tmax > 6 s, 
Fig. 4. A and B Illustrates baseline volumetric measure of early ischemic changes detected on non-contrast computed tomography images (NCCTcore, orange dot) and 
estimated relative cerebral blood flow (CBF) below 30% of normal brain (colored in grey bar) volumes, follow-up infarction volume (black dot) in 24 h follow-up 
NCCT and tissue at risk of infarction in the absence of reperfusion (penumbra, Tmax > 6 s, mL, colored in light blue bar) of all patients with NCCTcore ≥ 70 mL (n = 23) 
in milliliters (mL). 
Volume of tissue saved (mL) in individual patients with or without acute recanalization treatment (IVT; Intravenous thrombolysis, EVT;Endovascular treatment) 
marked as + >0 mL and – if <0 mL). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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penumbra) of all patients that had NCCTcore ≥ 70 mL (n = 23). 
As Fig. 4A illustrates, from the 23 patients with NCCTcore ≥ 70 mL, 13 
(57%) patients had also CTPcore ≥ 70 mL. Despite the large ischemic core 
(>70 ml) in NCCT, IVT, EVT or both were given to 12 patients; only 4 of 
them benefitted from the treatment (tissue saved in cases 7, 17, 20 and 
23, Fig. 4B) of which 3 (cases 17,20,23) were treated with EVT. In other 
13 patients who had CTPcore > 70 mL NCCTcore was below 70 mL. 
Out of the 52 patients with NCCTcore > 50 mL, 23 (44%) had also 
CTPcore > 50 mL. Despite NCCTcore > 50 mL, IVT, EVT or both were 
given to 31 (60%) patients. Of them, 17 (55%) patients had CTPcore ≤ 50 
with tissue saved in 10 (59%) patients. EVT therapy alone or with IVT 
resulted in successful recanalization in 50% of patients with NCCTcore >
50 mL and in 43% in patients with NCCTcore ≥ 70 mL (cases 4,7 and 20). 
More detailed information of patients with NCCTcore ≥ 70 mL and acute 
recanalization treatment and patients with CTPcore ≥ 70 mL are pro-
vided in supplemental material. 
The NCCTcore showed sensitivity of 77%, specificity of 89% and 
positive predictive value of 44% against the established FIV > 50 mL 
criterion. The NCCTcore showed sensitivity of 45%, specificity of 96% 
and positive predictive value of 57% against the established FIV ≥70 mL 
criterion. 
The performance of NCCTcore and CTPcore in predicting a FIV of >50 
mL and ≥ 70 ml was analyzed in ROC-curves (Fig. 5A and B) among all 
288 patients. 
NCCTcore and CTPcore performed similarly well in predicting both 
FIV > 50 mL (AUC 0.80, SE 0.033, p < 0.001, CI 0.73–0.86 and AUC 
0.82, SE 0.031, p < 0.001, CI 0.76–0.88)) and FIV ≥ 70 mL (AUC 0.80, 
SE 0.037, p < 0.001, CI 0.73–0.87 and AUC 0.82, SE 0.035, p < 0.001, CI 
0.73–0.87). There was no significant difference between AUCs of 
NCCTcore and CTPcore in both FIV > 50 mL (difference –0.02, SE 0.06, p 
= 0.73) and FIV ≥ 70 mL (difference − 0.02, SE 0.08, p = 0.79). 
4. Discussion 
Our aim was to study NCCTcore as selection tool for EVT without 
knowledge of CTP or CTA data. The present study shows that exclusion 
criterion of NCCTcore ≥ 70 mL at baseline exhibited sensitivity of only 
45% against the FIV ≥70 mL criterion although good negative predictive 
value. 3 patients with NCCTcore ≥ 70 mL seemed to have benefitted from 
EVT, despite a CTPcore > 70 mL and thus did not fulfill the guideline 
recommendations [4,11]. There was no significant difference between 
NCCTcore and CTPcore volumes among patients imaged >6 h of symptom 
onset compared to other patients even though the median difference was 
smaller compared with other patients (9 mL vs. 12 mL, p > 0.05). An 
NCCT based identification of patients that will not benefit from revas-
cularization treatments could save resources at smaller stroke centers by 
avoiding the transfers of patients with suspected LVO to comprehensive 
stroke centers. NCCT is usually readily available in every emergency 
room treating stroke patients. 
ROC-curve analysis showed that both NCCTcore and CTPcore had 
similar performance in predicting FIV. CTPcore has been successfully 
shown to predict final infarction volume on follow-up imaging at 24 h in 
patients with successful recanalization and Tmax > 6 s has performed 
well in predicting subsequent infarct volume in patients who did not 
achieve reperfusion in prior studies [5,12,20].. The NCCTcore and 
CTPcore are measured with different algorithms, which could have effect 
on baseline variation. The NCCTcore volume as quantified using volu-
metric measure by e-ASPECTS software seems to overestimate the 
ischemic core volume in comparison with CTPcore. As 33 (11%) patients 
had ischemia only in the vascular territory of ACA or PCA on follow-up 
imaging, only 4 patients had baseline NCCTcore of 0 mL even though e- 
ASPECTS software detects signs of early ischemic damage only in AS-
PECTS regions. 
To our knowledge, NCCTcore has not been studied as a screening tool 
of candidates for endovascular treatment. It was shown in recent study 
of Nagel et al. that e-ASPECTS-derived automatically derived acute 
ischemic volumes (NCCTcore) from NCCT correlated strongly with 
comprehensive magnetic resonance imaging volumes as well as CTP 
ischemic “core” volumes although this was studied in a small cohort (n 
= 41) and. [21] A recent study showed comparable agreement between 
NCCTcore and CTPcore against FIV in a large, prospectively collected 
cohort of fully reperfused EVT patients [22]. Our study results are in line 
with previous studies as patients with successful recanalization had 
smaller median difference between NCCTcore and FIV (p = 0.002) 
compared with other patients [21,22]. The strength of our study is that 
we studied NCCTcore as screening tool among stroke code patients, not in 
EVT patients only. All patients were also imaged with CTP RAPID 
compared to study of Nagel et al. (Olea Sphere®)) which has been used 
successfully in large clinical trials. 
However, our study has several limitations. Due to the retrospective 
nature of the study, one must bear in mind, that all treatment decisions 
were based on baseline NCCT, CTA and CTP without knowledge of the 
calculated NCCTcore. CTPcore might overestimate ischemic core espe-
cially if imaging is performed <180 min of symptom or with fast suc-
cessful recanalization and the median time to imaging was 74 min in our 
study [23]. Considering the role as selection tool for EVT, the volumetric 
measure of EIC by e-ASPECTS is limited to MCA-territory, however all 
patients (100%) with NCCTcore > 50 mL and NCCTcore ≥ 70 mL had 
Fig. 5. Receiver operating characteristics (ROC) curves were generated for 
both volumetric measure of early ischemic changes detected on non-contrast 
computed tomography images (NCCTcore) and estimated relative cerebral 
blood flow (CBF) below 30% of normal brain (CTPcore) to analyze sensitivity 
and specificity of the dichotomized follow-up infarction volume in 24 h follow- 
up NCCT for both >50 mL and ≥ 70 mL volumes. Both NCCTcore and CTPcore 
performed similarly well in predicting follow-up infarction volume > 50 mL (A, 
((AUC 0.79, SE 0.035, p < 0.001, CI 0.72–0.86 and AUC 0.82, SE 0.032, p <
0.001, CI 0.76–0.88) and ≥ 70 mL (B, (AUC 0.79, SE 0.039, p < 0.001, CI 
0.72–0.87 and AUC 0.81, SE 0.037, p < 0.001, CI 0.74–0.89) in follow-up non- 
contrast computed tomography. 
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ischemia in MCA-territory in our cohort. If NCCTcore had been used as 
selection tool for EVT instead of CTPcore, a discrepancy of eligibility for 
EVT would have occurred in 43% patients. However, in 10 patients EVT 
was attempted despite of CTPcore > 70 mL, resulting in a smaller FIV 
than anticipated by the perfusion lesion in 6 cases. This suggests that 
CTPcore is not an optimal selection tool either. Surprisingly, the median 
NCCTcore volume was larger than CTPcore and FIV which may due to 
sensitivity of the algorithm to for example vasogenic edema in the early 
phase of infarction [24]. The FIV was measured by only one neurora-
diologist, however he was blinded to any other imaging or outcome 
data. As NCCT was used as imaging modality of follow-up imaging at 24 
h after the baseline imaging, underestimation of FIV might have 
occurred. 
Both NCCTcore and CTP RAPID should be used as decision support 
tools and clinical decision making is in the key role identification 
possible discrepancies between core estimates and clinical symptoms. 
5. Conclusions 
New NCCT based imaging biomarkers would be beneficial in clinical 
decision making especially with drip-and ship patients and when there is 
no straight access to CTP or comprehensive magnetic resonance imag-
ing. NCCTcore ≥ 70 mL at baseline should be further investigated as an 
exclusion tool for recanalization therapies, especially in EVT patients in 
the 6 to 24 h time window. 
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